Table 5 Problems in the reporting process of clinical trials
From: Quality problems of clinical trials in China: evidence from quality related studies
Section | Number | Item |
|---|---|---|
Abstract | 1 | Insufficient report of title, trials design, allocation concealment method, and trials registration [82, 88] |
Methods | 2 | Insufficient description of random allocation sequence, allocation concealment, blinding, data analysis, and the processing of missing data in method section [62, 64, 65, 67, 71,72,73, 83, 88,89,90,91,92,93,94,95,96] |
Results | 3 | Low report rate of subject’s flow chart and compliance [62, 73, 88] |
Discussion | 4 | Insufficient analysis of the causes of major adverse events [71] |
5 | Few studies mention and analyze the limitations of trials in detail [68] | |
Other | 6 | Studies published in Chinese have low rate of registration and incomplete outcome [65] |